Advertisement Sorrento, Karolinska Institutet partner to perform immuno-oncology research - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sorrento, Karolinska Institutet partner to perform immuno-oncology research

Sorrento Therapeutics has formed a partnership with the Karolinska Institutet (KI) in Stockholm, Sweden, to perform cutting-edge immuno-oncology research and to develop new natural killer (NK) cell-based therapies.

Under the agreement, Sorrento will sponsor preclinical and clinical research & development programs focused on NK biology as well as adoptive NK cell therapies and, in return, obtain full rights to the resulting discoveries and developments.

The research will be performed at KI, but there will also be an active research exchange with Sorrento R&D in San Diego. A joint steering committee with members from both Sorrento and KI will guide the program activities.

Karolinska Institutet dean of research Hans-Gustaf Ljunggren said: "Given the fact that NK cells were discovered at Karolinska Institutet, it is of course now exciting to take part in the ongoing developments involving these cells in settings of adoptive immunotherapies targeting human malignancies.

"We look forward to teaming up our world-leading NK cell experts with Sorrento’s outstanding scientific team to gain new insights into NK biology and applying these to develop novel cellular therapies."

Sorrento president and CEO Henry Ji said: "We are honored to work with the distinguished KI faculty on discovering and developing new adoptive NK cell immunotherapies.

"Through this partnership, Sorrento further establishes its subsidiary, TNK Therapeutics, as one of the premier companies in the cellular therapy space. Building upon the academic and clinical excellence at KI and Sorrento’s expertise in antibody research and development, our partnership will stimulate innovation and may ultimately lead to new ground breaking therapies to improve the lives of cancer patients and their caretakers."